Provided by Tiger Trade Technology Pte. Ltd.

Bruker

36.51
-1.0000-2.67%
Post-market: 36.510.00000.00%16:10 EST
Volume:3.45M
Turnover:126.53M
Market Cap:5.55B
PE:-231.41
High:37.79
Open:36.94
Low:36.11
Close:37.51
52wk High:56.22
52wk Low:28.53
Shares:151.94M
Float Shares:103.15M
Volume Ratio:1.04
T/O Rate:3.35%
Dividend:0.20
Dividend Rate:0.55%
EPS(TTM):-0.1578
EPS(LYR):0.7591
ROE:-1.09%
ROA:3.68%
PB:2.28
PE(LYR):48.10

Loading ...

These Analysts Cut Their Forecasts On Bruker Following Q4 Results

Benzinga
·
4 hours ago

UBS Adjusts Price Target on Bruker to $40 From $43, Maintains Neutral Rating

MT Newswires Live
·
4 hours ago

Bruker Is Maintained at Overweight by Barclays

Dow Jones
·
Yesterday

Stifel Nicolaus Reaffirms Their Hold Rating on Bruker (BRKR)

TIPRANKS
·
Yesterday

Bruker price target raised to $49 from $43 at UBS

TIPRANKS
·
Yesterday

Guggenheim Keeps Their Buy Rating on Bruker (BRKR)

TIPRANKS
·
Yesterday

U.S. RESEARCH ROUNDUP-Applied Materials, Humana, Waste Connections

Reuters
·
Yesterday

Bruker (BRKR) Q3 Loss Of US$62 Million Tests Bullish Margin Narratives

Simply Wall St.
·
Yesterday

Bruker Down Over 14%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk

Dow Jones
·
Yesterday

Bruker price target lowered to $50 from $55 at Jefferies

TIPRANKS
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
Yesterday

Stock Track | Bruker Plummets 14.52% Intraday After Q4 Earnings Miss Estimates

Stock Track
·
Yesterday

Stock Track | Bruker Plunges 6.69% in Pre-market After Q4 Profit Misses Estimates

Stock Track
·
Feb 12

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical

Reuters
·
Feb 12

BUZZ-Bruker falls after Q4 profit misses estimates

Reuters
·
Feb 12

Shares of Bruker Down 1.7% Premarket After Q4 Profit Miss

THOMSON REUTERS
·
Feb 12

GUIDANCE: (BRKR) Bruker Expects Full Year 2026 Adjusted EPS Range $2.10 - $2.15, vs. FactSet Est of $2.14

MT Newswires Live
·
Feb 12

Bruker Q4 revenue beats estimates on biopharma market recovery

Reuters
·
Feb 12

Bruker reports FY25 GAAP diluted loss per share of USD -0.15, down from profit, and non-GAAP EPS of USD 1.83

Reuters
·
Feb 12

BRIEF-Bruker Q4 Adjusted EPS USD 0.59 Vs. IBES Estimate USD 0.65

Reuters
·
Feb 12